Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Clinuvel Pharmaceuticals Limited is a specialty pharmaceutical company. It is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the United States of America, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). It has operations in Europe, Singapore, and the United States of America. It develops and manufactures NEURACTHEL (adrenocorticotropic hormone) in different formulations, to target neurological, endocrinological, and degenerative disorders. Its pharmaceutical product, PRENUMBRA, has been developed, and its use is to be expanded in the clinic from stroke to Parkinson's.
Find out what a historical investment in CLINUVEL PHARMACUTIC-SP ADR would be worth today using our CUVL stock calculator.
Buying CUVL shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in CLINUVEL PHARMACUTIC-SP ADR in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in CUVL
What is the ticker symbol of CLINUVEL PHARMACUTIC-SP ADR?
The ticker symbol for CLINUVEL PHARMACUTIC-SP ADR is CUVL.
How much is one share of CUVL?
One share of CUVL is valued at $4.71 as of 20 November 2026.
Does CUVL pay dividends?
Yes, CUVL does pay dividends.
What is the dividend yield for CUVL?
The dividend yield for CUVL is 0.75% as of 20 November 2026.
What is the 52-week high for CLINUVEL PHARMACUTIC-SP ADR stock?
The CLINUVEL PHARMACUTIC-SP ADR 52-week high stock price is $8.92.
What is the 52-week low for CLINUVEL PHARMACUTIC-SP ADR stock?
The CLINUVEL PHARMACUTIC-SP ADR 52-week low stock price is $4.71.
Can I buy CUVL shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CUVL shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CUVL on Stake
Buy CUVL from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of CUVL from only US$10 with fractional shares